将2003年8月-2007年12月住院的中晚期癌症患者268例随机分为两组,即参芪扶正注射液组134例(简称治疗组)及常规化疗组134例(简称对照组),进行临床对比观察,报告如下。1资料与方法1.1一般资料本组268例,男142例,女126例,年龄38~79岁。全部经病理或细胞学、内镜、CT、X线等方法检 A total of 268 patients with advanced cancer who were hospitalized from August 2003 to December 2007 were randomly divided into two groups: 134 patients in Shenqi Fuzheng injection group and 134 patients in conventional chemotherapy group (referred to as control group) Clinical contrast observation, the report is as follows. 1 Materials and Methods 1.1 General Information The group of 268 cases, 142 males and 126 females, aged 38 to 79 years. All by pathology or cytology, endoscopy, CT, X-ray and other methods